Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Angiotensin converting enzyme inhibitors [[electronic resource] /] / Anne N. DeBrue, editor
| Angiotensin converting enzyme inhibitors [[electronic resource] /] / Anne N. DeBrue, editor |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (252 p.) |
| Disciplina | 572/.744 |
| Altri autori (Persone) | DeBrueAnne N |
| Soggetto topico |
Angiotensin converting enzyme - Inhibitors
Kidneys - Diseases - Chemotherapy |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-60741-095-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""ANGIOTENSIN CONVERTING ENZYME INHIBITORS ""; ""Contents ""; ""Preface ""; ""Angiotensin Converting Enzyme Inhibitors ""; ""Abstract ""; ""Introduction � The Components of the Renin Angiotensin Aldosterone System (RAAS)""; ""Structure and Structure Activity Relationships of the ACEIs ""; ""Clinical Indications and Uses of the ACEIs ""; ""Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients ""; ""Conclusion/Post-Script ""; ""References ""; ""Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature ""
""Abstract """"Introduction ""; ""ACEI-Associated Cough ""; "" Hypersensitivity Reaction During Hemodialysis ""; ""ACEI-Associated Anemia ""; ""ACEI-Induced Lung Disease ""; ""References ""; ""Plant-Derived Substances as ACE Inhibitors � Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells ""; ""Abstract ""; ""Introduction ""; ""Aim of this Study ""; ""Material and Methods ""; ""Results (Table 1) ""; ""Conclusion ""; ""Acknowledgments ""; ""References "" ""The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease """"Abstract""; ""Introduction ""; ""Effects of ACE inhibitors on Renal and Glomerular Hemodynamics ""; ""Effects of ACE Inhibitors on Proteinuria ""; ""Increasing the Doses of ACE Inhibitors or the Addition of ARB? ""; ""Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure ""; ""Upper Limit of Serum Creatinine to Add on ACE Inhibitor ""; ""Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors "" ""Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure """"Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors ""; ""Compliance of Taking ACE Inhibitors ""; ""Additional Therapy with ACE Inhibitors ""; ""Clinical Approach for Proper Use of ACE Inhibitors ""; ""Summary ""; ""Patients and Methods ""; ""Acknowledgements ""; ""References ""; ""Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function ""; ""Abstract ""; ""Abbreviation: ""; ""* Median follow-up "" ""Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD """"Clinical Uses of ACEI in Cardiovascular Diseases ""; ""Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function ""; ""Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial ""; ""Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD ""; ""Putting it Together ""; ""References "" ""Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition"" |
| Record Nr. | UNINA-9910452182703321 |
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiotensin converting enzyme inhibitors [[electronic resource] /] / Anne N. DeBrue, editor
| Angiotensin converting enzyme inhibitors [[electronic resource] /] / Anne N. DeBrue, editor |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (252 p.) |
| Disciplina | 572/.744 |
| Altri autori (Persone) | DeBrueAnne N |
| Soggetto topico |
Angiotensin converting enzyme - Inhibitors
Kidneys - Diseases - Chemotherapy |
| ISBN | 1-60741-095-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""ANGIOTENSIN CONVERTING ENZYME INHIBITORS ""; ""Contents ""; ""Preface ""; ""Angiotensin Converting Enzyme Inhibitors ""; ""Abstract ""; ""Introduction � The Components of the Renin Angiotensin Aldosterone System (RAAS)""; ""Structure and Structure Activity Relationships of the ACEIs ""; ""Clinical Indications and Uses of the ACEIs ""; ""Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients ""; ""Conclusion/Post-Script ""; ""References ""; ""Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature ""
""Abstract """"Introduction ""; ""ACEI-Associated Cough ""; "" Hypersensitivity Reaction During Hemodialysis ""; ""ACEI-Associated Anemia ""; ""ACEI-Induced Lung Disease ""; ""References ""; ""Plant-Derived Substances as ACE Inhibitors � Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells ""; ""Abstract ""; ""Introduction ""; ""Aim of this Study ""; ""Material and Methods ""; ""Results (Table 1) ""; ""Conclusion ""; ""Acknowledgments ""; ""References "" ""The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease """"Abstract""; ""Introduction ""; ""Effects of ACE inhibitors on Renal and Glomerular Hemodynamics ""; ""Effects of ACE Inhibitors on Proteinuria ""; ""Increasing the Doses of ACE Inhibitors or the Addition of ARB? ""; ""Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure ""; ""Upper Limit of Serum Creatinine to Add on ACE Inhibitor ""; ""Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors "" ""Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure """"Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors ""; ""Compliance of Taking ACE Inhibitors ""; ""Additional Therapy with ACE Inhibitors ""; ""Clinical Approach for Proper Use of ACE Inhibitors ""; ""Summary ""; ""Patients and Methods ""; ""Acknowledgements ""; ""References ""; ""Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function ""; ""Abstract ""; ""Abbreviation: ""; ""* Median follow-up "" ""Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD """"Clinical Uses of ACEI in Cardiovascular Diseases ""; ""Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function ""; ""Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial ""; ""Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD ""; ""Putting it Together ""; ""References "" ""Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition"" |
| Record Nr. | UNINA-9910779516703321 |
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Angiotensin converting enzyme inhibitors / / Anne N. DeBrue, editor
| Angiotensin converting enzyme inhibitors / / Anne N. DeBrue, editor |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (252 p.) |
| Disciplina | 572/.744 |
| Altri autori (Persone) | DeBrueAnne N |
| Soggetto topico |
Angiotensin converting enzyme - Inhibitors
Kidneys - Diseases - Chemotherapy |
| ISBN | 1-60741-095-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""ANGIOTENSIN CONVERTING ENZYME INHIBITORS ""; ""Contents ""; ""Preface ""; ""Angiotensin Converting Enzyme Inhibitors ""; ""Abstract ""; ""Introduction � The Components of the Renin Angiotensin Aldosterone System (RAAS)""; ""Structure and Structure Activity Relationships of the ACEIs ""; ""Clinical Indications and Uses of the ACEIs ""; ""Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients ""; ""Conclusion/Post-Script ""; ""References ""; ""Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature ""
""Abstract """"Introduction ""; ""ACEI-Associated Cough ""; "" Hypersensitivity Reaction During Hemodialysis ""; ""ACEI-Associated Anemia ""; ""ACEI-Induced Lung Disease ""; ""References ""; ""Plant-Derived Substances as ACE Inhibitors � Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells ""; ""Abstract ""; ""Introduction ""; ""Aim of this Study ""; ""Material and Methods ""; ""Results (Table 1) ""; ""Conclusion ""; ""Acknowledgments ""; ""References "" ""The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease """"Abstract""; ""Introduction ""; ""Effects of ACE inhibitors on Renal and Glomerular Hemodynamics ""; ""Effects of ACE Inhibitors on Proteinuria ""; ""Increasing the Doses of ACE Inhibitors or the Addition of ARB? ""; ""Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure ""; ""Upper Limit of Serum Creatinine to Add on ACE Inhibitor ""; ""Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors "" ""Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure """"Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors ""; ""Compliance of Taking ACE Inhibitors ""; ""Additional Therapy with ACE Inhibitors ""; ""Clinical Approach for Proper Use of ACE Inhibitors ""; ""Summary ""; ""Patients and Methods ""; ""Acknowledgements ""; ""References ""; ""Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function ""; ""Abstract ""; ""Abbreviation: ""; ""* Median follow-up "" ""Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD """"Clinical Uses of ACEI in Cardiovascular Diseases ""; ""Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function ""; ""Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial ""; ""Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD ""; ""Putting it Together ""; ""References "" ""Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition"" |
| Record Nr. | UNINA-9910823536103321 |
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Calcium channel blockers and renal disease [[electronic resource] /] / [edited by] Nicolas Roberto Robles
| Calcium channel blockers and renal disease [[electronic resource] /] / [edited by] Nicolas Roberto Robles |
| Pubbl/distr/stampa | Hauppauge, NY, : Nova Science Publishers, c2009 |
| Descrizione fisica | 1 online resource (195 p.) |
| Disciplina | 616.6/1061 |
| Altri autori (Persone) | RoblesNicolas Roberto |
| Collana | Cerebrovascular Research and Disorders |
| Soggetto topico |
Kidneys - Diseases - Chemotherapy
Calcium - Antagonists |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61209-867-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910465219203321 |
| Hauppauge, NY, : Nova Science Publishers, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Calcium channel blockers and renal disease [[electronic resource] /] / [edited by] Nicolas Roberto Robles
| Calcium channel blockers and renal disease [[electronic resource] /] / [edited by] Nicolas Roberto Robles |
| Pubbl/distr/stampa | Hauppauge, NY, : Nova Science Publishers, c2009 |
| Descrizione fisica | 1 online resource (195 p.) |
| Disciplina | 616.6/1061 |
| Altri autori (Persone) | RoblesNicolas Roberto |
| Collana | Cerebrovascular Research and Disorders |
| Soggetto topico |
Kidneys - Diseases - Chemotherapy
Calcium - Antagonists |
| ISBN | 1-61209-867-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910791815603321 |
| Hauppauge, NY, : Nova Science Publishers, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Calcium channel blockers and renal disease / / [edited by] Nicolas Roberto Robles
| Calcium channel blockers and renal disease / / [edited by] Nicolas Roberto Robles |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hauppauge, NY, : Nova Science Publishers, c2009 |
| Descrizione fisica | 1 online resource (195 p.) |
| Disciplina | 616.6/1061 |
| Altri autori (Persone) | RoblesNicolas Roberto |
| Collana | Cerebrovascular Research and Disorders |
| Soggetto topico |
Kidneys - Diseases - Chemotherapy
Calcium - Antagonists |
| ISBN | 1-61209-867-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- CALCIUM CHANNEL BLOCKERSAND RENAL DISEASE -- CALCIUM CHANNEL BLOCKERS AND RENAL DISEASE -- Contents -- Preface -- List of Authors -- Pharmacology of CalciumAntagonists -- Mechanisms of Action -- Differences among Calcium-Antagonists -- Clinical Pharmacology -- Pharmacokinetics -- Pharmacodynamics -- Tolerance -- Sympathetic Activation -- Ankle edema -- Other Untoward Effects -- Therapeutic Uses -- Hypertension -- Angina Pectoris -- Supraventricular Arrhythmias -- Subarachnoid Hemorrhage -- Myocardial Infarction -- Risk of Cancer -- Drug Interactions -- Special Considerations -- Older Patients -- Metabolic Syndrome -- Patients with Congestive Heart Failure -- Overdose of CCBs -- References -- Calcium Antagonists and SystemicHypertension -- Abstract -- Calcium Channel Blockers:The Findings of Clinical Trials -- Calcium Channel Blockers and Target OrganDisease -- 1. Calcium Channel Blockers and Arteriosclerosis -- 2. Use of Calcium Channel Antagonists in Coronary Disease(CHD) -- 3. Effects on Cerebrovascular Disease: Clinical Trials -- 4. Meta-Analysis on Cerebrovascular Outcomes -- Conclusions -- References -- Effects of Calcium Antagonists inRenal Hemodynamics -- Abstract -- 1. Ca2+ Channels and Vasoconstriction -- 1.1. Diversity of Ca2+ Channels -- 1.2. The Traditional Vision: The Role of L-Type Ca2+ Channels -- 1.3. The Emerging Evidences for Other Types of Ca2+ Channels -- 2. The Use of CCBs for BP Control inHypertension -- 2.1. The Principle of Ca2+ Antagonism -- 2.2. The Mechanism of "Ca2+ Antagonism" in Hypertension -- 3. Effects of CCBs on Microcirculation andRenal Hemodynamics -- 3.1. CCBs and Renal Protection -- 3.2. Mechanisms for Beneficial Renal Effects of New CCBs -- 3.2.1. DHP-Insensitive Ca2+ Channels in the Microcirculation andKidneys -- 3.2.2. DHP-Insensitive Ca2+ Channels in the Sympathetic Nerves.
3.2.3. New DHPs Cause New Effects on Renal Function -- 3.2.4. Limitations and Pertaining Questions -- Conclusion - Prospects -- References -- The Non-Hemodynamic Effects ofCalcium Channel Blockers on theKidney -- 1. Introduction -- 2. Antioxidant Effects -- 2.1. End-Stage Renal Disease -- 2.2. Diabetes -- 2.3. Effects of Associations -- 3. Effect on the Proliferation of MesangialCells -- 4. Effect on Fibrosis and Apoptosis -- 5. Other Effects -- Summary -- References -- Renoprotective Effect of CalciumAntagonists in SystemicHypertension -- Introduction -- Overview of Relevant Trials Regarding CCBsand Renal Protection in HypertensivePatients -- CCBs and Renal Protection in the Presenceof Preserved Renal Function -- Blood Pressure Control andNephroprotection in Patients withEstablished Chronic Kidney Disease -- Conclusions -- References -- Calcium Antagonists and RenalDisease -- Introduction -- Effects Calcium Channel Blockers on RenalHemodynamics -- Renoprotective Effect of CalciumAntagonists in Animals -- Effects on the Progression of Renal Injuryin Humans -- Calcium Antagonists versus Renin-Angiotensin Axis Blocking Drugs -- Calcium Antagonists versus Diuretics -- Comparison between Calcium-Antagonists -- New Calcium Antagonists -- Conclusion -- References -- Renal Ischaemia and CalciumChannel Blockers (CCBs) -- Introduction -- Chronic Renal Ischaemia -- Definition -- Pathogenic Mechanisms -- Epidemiology -- Morphology -- Clinical Presentation -- Calcium Channel Blockers and RID -- Contrast-Induced Nephropathy AND CCBs -- Risk Factors OF CIN -- Prevention of Radiocontrast Nephropathy -- References -- Calcium Antagonist after KidneyTransplantation -- Drug Treatment in Post-TransplantationArterial Hypertension -- References -- Non Dihydropyridinic CalciumAntagonists and Renal Disease. Nondihydropiridine Calcium ChannelBlockers vs Other Antihypertensive Agents -- Combination Therapy -- Conclusions -- References -- Index. |
| Record Nr. | UNINA-9910818421503321 |
| Hauppauge, NY, : Nova Science Publishers, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
